3 active not recruiting, 1 recruiting. 2 Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Recruiting 1 |
| Not applicable | 1 | Active not recruiting 1 |
Follow Pathologic Stage IB Cutaneous Melanoma AJCC v8: new trials by email Literature Review of Pathologic Stage IB Cutaneous Melanoma AJCC v8 trials Research Report on Pathologic Stage IB Cutaneous Melanoma AJCC v8
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors Medical Device Usage and Evaluation, Quality-of-Life Assessment, Survey Administration - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Active not recruiting | University of Southern California | 173 | 2021-11-24 | 2026-10-05 | |
| Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer Best Practice, Biospecimen Collection, Endoscopic Procedure - Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8 | Phase 1 | Recruiting | M.D. Anderson Cancer Center | 800 | 2021-02-21 | 2026-07-15 |
| The Impact of an Antibiotic (Cefazolin) Before Surgery on the Microbiome in Patients With Stage I-II Melanoma Cefazolin, Resection - Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8 | Phase 1 | Active not recruiting | M.D. Anderson Cancer Center | 20 | 2020-09-08 | 2026-05-20 |
| Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their Families Informational Intervention, Survey Administration - Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8 | Not applicable | Active not recruiting | Rutgers, The State University of New Jersey | 1160 | 2019-06-03 | 2026-05-22 |
Bone Neoplasms (1) · Brain Neoplasms (1) · Carcinoma, Medullary (1) · Carcinoma, Non-Small-Cell Lung (1) · Central Nervous System Neoplasms (1) · Colitis (1) · Colorectal Neoplasms (1) · Hodgkin Disease (1) · Lung Neoplasms (1) · Lymphoma, Non-Hodgkin (1) · Ovarian Neoplasms (1) · Testicular Neoplasms (1) · Urogenital Neoplasms (1) · Uterine Cervical Neoplasms (1)
Colonic Diseases (2) · Digestive System Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Gastrointestinal Diseases (2) · Intestinal Diseases (2) · Male Urogenital Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Urogenital Diseases (2) · Adenocarcinoma (1) · Adnexal Diseases (1) · Bone Diseases (1) · Brain Diseases (1) · Bronchial Neoplasms (1)
CT-P13 (1) · Cefazolin (1) · Disulfides (1) · Endoscopy (1) · Fecal Microbiota Transplantation (1) · Immunoglobulin G (1) · Infliximab (1) · LDP-02 (1) · Practice Guidelines as Topic (1) · Prednisone (1) · Standard of Care (1) · deltacortene (1) · prednylidene (1) · vedolizumab (1)
M.D. Anderson Cancer Center (2) · Rutgers, The State University of New Jersey (1) · University of Southern California (1)
United States (4)
Emily Z Keung (1) · Kimberly Miller, PhD (1) · Sharon Manne (1) · Yinghong Wang (1)
P30CA014089 (1), R01CA221854 (1), R37CA256867 (1)